Discuss your research with your peers
Would you like to react to this message? Create an account in a few clicks or log in to continue.
Discuss your research with your peers

Real time streaming news at http://www.myresearchnews.com

The website is brand new, you are helping us evolve. Please help us by contributing your thoughts on any topic, leave a comment, start a new discussion. Thanks a lot.

Evaluation of Exon-Skipping Strategies for Duchenne Muscular Dystrophy Utilizing Dystrophin-deficient Zebrafish

Discuss your research with your peers :: Molecular Biology :: Antisense Forum

Go down

Evaluation of Exon-Skipping Strategies for Duchenne Muscular Dystrophy Utilizing Dystrophin-deficient Zebrafish Empty Evaluation of Exon-Skipping Strategies for Duchenne Muscular Dystrophy Utilizing Dystrophin-deficient Zebrafish

Post  Jon Moulton Mon Jan 24, 2011 9:37 am

Berger J, Berger S, Jacoby AS, Wilton SD, Currie PD. Evaluation of Exon-Skipping Strategies for Duchenne Muscular Dystrophy Utilizing Dystrophin-deficient Zebrafish. J Cell Mol Med. 2011 Jan 20. doi: 10.1111/j.1582-4934.2011.01260.x. [Epub ahead of print]
Jon Moulton
Jon Moulton

Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA

http://www.gene-tools.com

Back to top Go down

Back to top

- Similar topics
» Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production
» Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy
» Exon 53 skipping of the dystrophin gene in patients with Duchenne muscular dystrophy by systemic administration of NS-065/NCNP-01: A phase 1, dose escalation, first-in-human study
» Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
» Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Discuss your research with your peers :: Molecular Biology :: Antisense Forum

 
Permissions in this forum:
You cannot reply to topics in this forum